| 标题 |
7MO Becotarug (JMT101) and osimertinib (Osi) in patients (pts) with platinum-pretreated EGFR exon 20 insertion-mutated (ex20ins) non-small cell lung cancer (NSCLC): Final overall survival (OS) and subgroup analyses from the BECOME phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:L. Zhang; W.F. Fang; Y. Huang; S. Zhao; Y. Yu; et al 出版日期:2026-04-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)